[HTML][HTML] The Spectrum of Molecular Pathways in Gliomas—An Up-to-Date Review

R Nafe, E Hattingen - Biomedicines, 2023 - mdpi.com
During the last 20 years, molecular alterations have gained increasing significance in the
diagnosis and biological assessment of tumors. Gliomas represent the largest group of …

Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches

MJ Riemenschneider… - Current opinion in …, 2009 - journals.lww.com
Novel insights into the pathogenesis of gliomas based on lar... : Current Opinion in
Neurology Novel insights into the pathogenesis of gliomas based on large-scale molecular …

[HTML][HTML] Molecular biology of gliomas: present and future challenges

R Altieri, A Agnoletti, F Quattrucci… - Translational …, 2014 - ncbi.nlm.nih.gov
Malignant brain tumours are one of the most relevant causes of morbidity and mortality
across a wide range of individuals. Malignant glioma is the most common intra axial tumor in …

Altered molecular pathways in gliomas: an overview of clinically relevant issues

RD Rao, CD James - Seminars in oncology, 2004 - Elsevier
Primary central nervous system (CNS) tumors constitute a small fraction of the overall
incidence of human cancer, but they represent a major source of cancer-related morbidity …

Beyond Genetics in Glioma Pathways: The Ever‐Increasing Crosstalk between Epigenomic and Genomic Events

R Martínez - Journal of signal transduction, 2012 - Wiley Online Library
Diffuse gliomas are the most frequent brain tumor in adults. This group of brain neoplasms,
ranging from histologically benign to aggressive malignant forms, represents a challenge in …

A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know

PD Delgado-López, P Saiz-López, R Gargini… - Clinical and …, 2020 - Springer
The molecular biology of human glioma is a complex and fast-growing field in which basic
research needs to meet clinical expectations in terms of anti-tumor efficacy. Although much …

New molecular targets in malignant gliomas

JF De Groot, MR Gilbert - Current opinion in neurology, 2007 - journals.lww.com
Technologic advances in oncogenomics, proteomics and functional genomic screens (such
as synthetic lethality) are providing mechanisms to rapidly identify the critical targets whose …

[HTML][HTML] Forms of Non-Apoptotic Cell Death and Their Role in Gliomas—Presentation of the Current State of Knowledge

R Nafe, E Hattingen - Biomedicines, 2024 - mdpi.com
In addition to necrosis and apoptosis, the two forms of cell death that have been known for
many decades, other non-apoptotic forms of cell death have been discovered, many of …

[HTML][HTML] Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance

A Bezawork-Geleta, J Dimou, MJ Watt - Frontiers in Oncology, 2022 - frontiersin.org
A primary brain tumor glioblastoma is the most lethal of all cancers and remains an
extremely challenging disease. Apparent oncogenic signaling in glioblastoma is genetically …

Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways

H Li, J Liu, X Qin, J Sun, Y Liu, F Jin - Cellular and Molecular …, 2023 - Springer
Gliomas are a deadly primary malignant tumor of the central nervous system, with
glioblastoma (GBM) representing the most aggressive type. The clinical prognosis of GBM …